As XHIM is a monogenic disorder, previous studies have aimed to identify approaches to restore expression of wild-type (WT) CD40L protein in XHIM T cells or hematopoietic stem and progenitor cells (HSPCs). The gene discussed is CD40LG; the disease is hyper-IgM syndrome type 1.